Sodium Chloride

• 125 mL Syringe:  Sodium Chloride Injection USP 0.9% is indicated for use in flushing compatible contrast agents through Liebel-Flarsheim intravenous administration sets into indwelling intravascular access devices only when delivered by the following Liebel-Flarsheim power injectors: Angiomat^®, Illumena^®, Illumena^® Néo, CT9000^®, CT9000^® ADV, Optistat^®, Optivantage^® and Optistar Elite.

• The 125 mL syringe are for single patient use only.
• Determine the volume of the saline flush for each patient individually based, in part, on the imaging procedure, the location of the vascular access device, the length of tubing between the Liebel-Flarsheim contrast agent power injector and the vascular access device and the recommendations made on the package insert for the contrast agent. Typical Sodium Chloride Injection USP 0.9% flush volumes following contrast agent administration in adults are 10 to 25 mL per injection at rates not to exceed 10 mL/sec.
• Use of some Liebel-Flarsheim contrast agent power injectors allows for additional infusion of Sodium Chloride Injection USP 0.9% to maintain the patency of vascular access. Typical infusion rates used for this purpose are in the range of 0.5 to 1 mL per minute.
• Individualize infusion rates and flush volumes for each patient based on their body weight, fluid status and concomitant medical conditions.
• Consult the Liebel-Flarsheim contrast agent power injector manual for proper use.

Sodium Chloride Injection USP (0.9%)

• a clear, colorless, odorless solution
• supplied in 125 mL prefilled syringes
• contents are sterile

Reported adverse reactions include:

• air embolization with stroke, chest pain, and dyspnea
• arrhythmia
• hypotension
• myocardial infarction
• sepsis
• febrile response
• local tenderness
• infection at the site of injection
• venous thrombosis or phlebitis extending from injection site
• extravasation
• fluid overload
• hypervolemia

Sodium Chloride Injection USP 0.9% is a formulation of sodium chloride in Water for Intravascular Injection. No preservative, antimicrobial agent or buffer is added. Sodium Chloride Injection USP 0.9% is provided as a sterile, nonpyrogenic, clear, colorless, odorless solution.